GlassScriptPhysician profile
Kara Wedding
NPI 1316519721
$1,624.35
in general payments reported to CMS, 2019-2025
15 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.58 · 2022: $724 · 2023: $319 · 2024: $272 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $256.08 | 2022-2024 | Omnipod |
| Novo Nordisk INC | $196.52 | 2022-2023 | Wegovy |
| Medtronic, INC. | $148.70 | 2025 | Minimed 780g |
| Angiodynamics, INC. | $129.17 | 2023 | Auryon Laser System 100-120 Vac |
| Sequel Med Tech, LLC | $122.38 | 2025 | Twiist |
| Sanofi-Aventis U.S. LLC | $119.70 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $107.10 | 2022 | |
| Dexcom, INC. | $103.86 | 2022-2024 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $103.78 | 2022 | |
| Evoke Pharma, INC. | $90.17 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $88.20 | 2022 | |
| Beta Bionics, INC. | $73.33 | 2024 | Ilet Bionic Pancreas |
| Agile Therapeutics, INC. | $38.58 | 2021 | |
| Abbvie INC. | $32.10 | 2022 | |
| Currax Pharmaceuticals LLC | $14.68 | 2023 | Contrave, Nexlizet, Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Wedding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.